Imunoriks - instructions for use, analogs, reviews and release forms (solution or drops 400 mg) of the medicinal immunomodulator for the treatment and prevention of influenza and other acute respiratory viral infections in adults, children and pregnancy. Composition

In this article, you can read the instructions for using the drug Imunoriks. There are reviews of visitors to the site - consumers of this medication, as well as opinions of specialists on the use of Imunoriks in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Imunoriks in the presence of existing structural analogues. Use for the treatment and prevention of influenza and other acute respiratory viral infections in adults, children,as well as during pregnancy and lactation. Composition of the preparation.

Imunoriks - immunostimulating drug. Pidotimod (the active substance of the drug Imunoriks) stimulates and regulates cellular and humoral immunity in conditions of immunodeficiency. Effects on T-cell immunity: Pidotimod enhances the activity of natural killers and activates phagocytosis. Effects on humoral immunity: Pidotimod increases the production of cytokines.

Composition

Pidotimod + auxiliary substances.

Pharmacokinetics

Studies on volunteers showed a high level of absorption of the drug when ingested. Bioavailability is 45%.

Indications

As part of complex therapy:

• immunocorrection in bacterial, fungal and viral infections of the upper and lower respiratory tract;
• immunocorrection in bacterial, fungal and viral infections of the urinary tract.

Forms of release

Solution for ingestion 400 mg (sometimes mistakenly called drops).

Instructions for use and dosing regimen

Adults for 800 mg pidotimoda (2 bottles) 2 times a day outside meals for 15 days. The daily dose of the drug should not exceed 1600 mg.

Children over 3 years of 400 mg pidotimoda (1 bottle) 2 times a day outside meals for 15 days. The daily dose of the drug at the reception should not exceed 800 mg.

Doses and duration of the drug can be adjusted depending on the severity and severity of the symptoms of the disease. The duration of the course is not more than 90 days.

Side effect

• allergic reactions.

Contraindications

• children under 3 years;
• hypersensitivity to the components of the drug.

Application in pregnancy and lactation

Imunoriks is not recommended for use during pregnancy and lactation (lactation).

In experimental studies on animals embryotoxic and teratogenic effects of the drug was not observed.

Use in children

Contraindicated in children under 3 years.

special instructions

Use with caution in patients with hyperimmunoglobulinemia syndrome E, allergic reactions in the anamnesis.

Impact on the ability to drive vehicles and manage mechanisms

The drug does not affect the ability to drive vehicles and control mechanisms.

Drug Interactions

The drug can influence the effectiveness of drugs that suppress or stimulate the functional activity of lymphocytes.

Analogues of the drug Imunoriks

There are no structural analogs to the active substance of the drug Imunoriks.

Analogues for the pharmacological group (immunomodulators):

• Actipol;
• Anaferon;
• Anaferon child;
• Arbidol;
• Bronho Vaxom;
• Bronhomunal;
• Wobenzym;
• Galavit;
• Groprinosin;
• Derinat;
• Zadaxin;
• Immunal;
• Imudon;
• IRS 19;
• Yodantipyrine;
• Lycopid;
• Myelopid;
• Neuroferon;
• ORITOL NP;
• Pantohematogen;
• Pyrogenal;
• Polyoxidonium;
• Posterizan;
• Posterizan forte;
• Profetal;
• Ribomunyl;
• Ruzam;
• Splenin;
• Stimforte;
• Tactivin;
• Timalin;
• Timogen;
• Timoptin;
• Timusamine;
• Tonzylgon H;
• Trekrezan;
• Uro Vaxom;
• Cytovir 3;
• Erbisol;
• Ergoferon;
• Estifan;
• Echinacea;
• Echinocor.

Similar medicines:

Other medicines: